Last updated 26 days ago

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

600 patients around the world

Available in Spain, Mexico, United States

Pfizer

5Research sites

600Patients around the world

This study is for people with

Migraine

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Centro de Investigación Médica Aguascalientes - CIMA

Av Independencia 2130, Trojes de Alonso, Aguascalientes

Clinstile S.A de C.V.

Durango 325, Roma Norte, Ciudad de México

Clinical Research Institute S.C.

Blvd. Manuel Ávila Camacho 1994, Colonia San Lucas Tepetlacalco, Tlalnepantla de Baz, Ciudad de México

Medical Care & Research SA de CV

Calle 32 217 por Calle 11 y 13, Colonia Garcia Gineres, CP 97070 - Yucatán, Mérida

Unidad de Investigación en Salud de Chihuahua S.C

Av. Renato Leduc No.151, Interior 4 Col. Toriello Guerra

SponsorPfizer

Conditions

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05518123